Showing results (341-350 of 436) with videos related to

Sort By:
Pageof 44
Intensive Care Medicine Experimental|January 7, 2026
Direct RNA sequencing identified solute carrier family 2 member 1 to improve neurological outcome prediction after cardiac arrestVictoria Stopa, Miron Sopic, Lu Zhang, et al.
BMJ Open Respiratory Research|July 2, 2019
Guidelines on the management of acute respiratory distress syndromeMark J D Griffiths, Danny Francis McAuley, Gavin D Perkins, et al.
Resuscitation|July 29, 2015
No difference in mortality between men and women after out-of-hospital cardiac arrestMatilde Winther-Jensen, Jesper Kjaergaard, Michael Wanscher, et al.
Acta Anaesthesiologica Scandinavica|May 16, 2018
Timing of onset of gastrointestinal bleeding in the ICU: Protocol for a preplanned observational studyA Granholm, T Lange, C T Anthon, et al.
Acta Anaesthesiologica Scandinavica|August 24, 2019
Time to onset of gastrointestinal bleeding in the SUP-ICU trial: A pre-planned substudyAnders Granholm, Theis Lange, Carl Thomas Anthon, et al.
JAMA Neurology|March 6, 2023
Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac ArrestNicholas J Ashton, Marion Moseby-Knappe, Andrea L Benedet, et al.
Ejhaem|August 19, 2024
Desmopressin for prevention of bleeding for thrombocytopenic, critically ill patients undergoing invasive procedures: A randomised, double-blind, placebo-controlled feasibility trialMichael J R Desborough, Emma Laing, Daphne Kounali, et al.
The New England Journal of Medicine|May 22, 2019
Early Sedation with Dexmedetomidine in Critically Ill PatientsYahya Shehabi, Belinda D Howe, Rinaldo Bellomo, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2022
Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose-associated 90-Day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE III)Yahya Shehabi, Ary Serpa Neto, Rinaldo Bellomo, et al.
Resuscitation|November 4, 2015
Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33 °C or 36 °CJohn Bro-Jeppesen, Jesper Kjaergaard, Pascal Stammet, et al.
Pageof 44